Major stock indexes in the United States presented a mixed picture recently, with the S&P 500 reaching an all-time high while the Dow Jones Industrial Average faced downward pressure. Despite these fluctuations, investors continue to explore diverse opportunities across various sectors. Penny stocks, often associated with smaller or newer companies, remain a compelling area for those seeking affordable entry points and potential growth. These stocks can offer significant value when they are backed by strong financials and clear paths to expansion.

Top 10 Penny Stocks In The United States

Name	Share Price	Market Cap	Rewards & Risks
Dingdong (Cayman) (DDL)	$2.76	$597.91M	✅ 3 ⚠️ 1 View Analysis >
Waterdrop (WDH)	$1.70	$618.44M	✅ 4 ⚠️ 0 View Analysis >
CuriosityStream (CURI)	$3.61	$211.04M	✅ 4 ⚠️ 2 View Analysis >
WM Technology (MAPS)	$0.8251	$142.82M	✅ 4 ⚠️ 1 View Analysis >
LexinFintech Holdings (LX)	$2.97	$503.11M	✅ 4 ⚠️ 2 View Analysis >
Tuya (TUYA)	$2.14	$1.3B	✅ 4 ⚠️ 1 View Analysis >
Golden Growers Cooperative (GGRO.U)	$5.00	$77.45M	✅ 1 ⚠️ 5 View Analysis >
Cricut (CRCT)	$4.40	$931.68M	✅ 2 ⚠️ 2 View Analysis >
BAB (BABB)	$0.9205	$7.07M	✅ 2 ⚠️ 3 View Analysis >
Lifetime Brands (LCUT)	$3.89	$88.13M	✅ 3 ⚠️ 2 View Analysis >

Underneath we present a selection of stocks filtered out by our screen.

U.S. Global Investors (GROW)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: U.S. Global Investors, Inc. is a publicly owned investment manager with a market cap of $33.95 million.

Operations: The company generates revenue of $8.55 million from its Investment Management Services segment.

Market Cap: $33.95M

U.S. Global Investors, Inc., with a market cap of US$33.95 million, has demonstrated resilience amid challenging conditions for penny stocks. The company reported first-quarter revenue of US$2.25 million and net income of US$1.51 million, reflecting improved earnings from the previous year. Despite negative earnings growth over the past five years, its seasoned management and board provide stability. Recent strategic shifts include transitioning its GO GOLD ETF to active management amidst record gold prices and celebrating the anniversary of its Technology and Aerospace & Defense ETF, underscoring a focus on thematic investment strategies in high-conviction market areas.

MacroGenics (MGNX)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: MacroGenics, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, manufacturing, and commercializing antibody-based cancer therapeutics in the United States with a market cap of approximately $113.87 million.

Operations: The company's revenue of $127.63 million is generated from its efforts in developing and commercializing monoclonal antibody-based therapeutics.

Market Cap: $113.87M

MacroGenics, Inc., with a market cap of US$113.87 million, faces challenges typical of penny stocks despite its focus on antibody-based cancer therapeutics. The company reported a decline in third-quarter revenue to US$72.84 million from the previous year and remains unprofitable with ongoing losses. However, it benefits from an experienced board and management team, and its short-term assets exceed both short- and long-term liabilities, indicating financial stability. Recent developments include leadership changes in clinical development following Dr. Stephen Eck's departure and removal from the NASDAQ Biotechnology Index, reflecting ongoing strategic adjustments amidst industry pressures.

Voip-Pal.com (VPLM)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Voip-Pal.com Inc. focuses on acquiring and developing Voice-over-Internet Protocol processes in the United States, with a market cap of $44.49 million.

Operations: Voip-Pal.com Inc. has not reported any specific revenue segments.

Market Cap: $44.49M

Voip-Pal.com Inc., with a market cap of US$44.49 million, is pre-revenue and faces typical challenges for penny stocks, including a high weekly volatility of 21% and an unprofitable status with increasing losses over the past five years. The company has less than a year of cash runway, raising concerns about its financial sustainability. Despite being debt-free and having short-term assets exceeding liabilities, its board lacks experience with an average tenure of 2.4 years. Recent earnings results showed reduced net losses to US$6.23 million for the year ended September 2025; however, auditors expressed doubts about its ability to continue as a going concern.

Turning Ideas Into Actions

• Click through to start exploring the rest of the 323 US Penny Stocks now.
• Looking For Alternative Opportunities? The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 23 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.